Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 24;37(5):1009–1013. doi: 10.1038/s41433-023-02428-9

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

PMC Copyright notice

Fig. 1 — a Lentiga maligna melanoma in situ (MIS) of the left lower eyelid. b Right upper eyelid melanocytic naevus and right lower eyelid lentigo maligna invasive melanoma. c Right upper eyelid amelanotic nodular invasive melanoma (T4bN3M1b Breslow 6 mm BRAF/NRAS negative). d Nodular invasive melanoma (pT4bN2bM1d-Breslow 16 mm Wildtype BRAF/mutant NRAS. NRAS mutant exon3 codon 61: potential for MEK inhibitor).